Offer to Purchase All Outstanding Shares of Common Stock of CymaBay Therapeutics, Inc. At $32.50 Net Per Share in Cash byPacific Merger • February 23rd, 2024 • Gilead Sciences, Inc. • Biological products, (no disgnostic substances)
Purchaser is offering to buy your securities. Purchaser has been organized in connection with this Offer and has not carried on any activities other than entering into the Agreement and Plan of Merger, dated as of February 11, 2024 (together with any amendments or supplements thereto, the “Merger Agreement”), by and among the Company, Parent and Purchaser, and activities relating to, or in connection with, the Offer. See Section 9 — “Certain Information Concerning Parent and Purchaser.”
